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Abstract 
Host prion (PrPC) genotype is a major determinant for the susceptibility to prion diseases. The Q/K222‑PrP
C polymor‑
phic variant provides goats and mice with high resistance against classical scrapie and bovine spongiform encepha‑
lopathy (BSE); yet its effect against atypical scrapie is unknown. Here, transgenic mice expressing the goat wild‑type 
(wt) or the K222‑PrP
C variant were intracerebrally inoculated with several natural cases of atypical scrapie from sheep 
and goat and their susceptibility to the prion disease was determined. Goat wt and K222‑PrP
C transgenic mice were 
100% susceptible to all the atypical scrapie isolates, showing similar survival times and almost identical disease 
phenotypes. The capacity of the K222‑PrP
C variant to replicate specifically the atypical scrapie strain as efficiently as the 
goat wt PrPC, but not the classical scrapie or cattle‑BSE as previously reported, further suggests the involvement of 
concrete areas of the host PrPC in the strain‑dependent replication of prions.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Scrapie is a fatal neurodegenerative disease of sheep and 
goats caused by the conversion of the host cellular prion 
protein (PrPC) into a pathological misfolded form (PrPSc). 
Scrapie occurs in a variety of phenotypes within two 
forms—classical and atypical scrapie forms—which differ 
in their incubation periods, clinical signs, neuropatho-
logical lesion profiles and/or PrPSc biochemical proper-
ties. The zoonotic potential of classical scrapie has been 
recently proposed from transmission studies of a panel 
of classical scrapie isolates in non-human primates [1] 
and in humanized transgenic mice [2], highlighting the 
necessity of deciphering the factors involved in prion 
transmission.
Susceptibility of sheep and goats to scrapie is strongly 
determined by the PrPc encoding gene (Prnp) and 
the prion strain. Strategies to promote breeding for 
the Prnp allele linked to classical scrapie resistance, 
A136R154R171, in sheep herds were implemented in some 
European countries and in the USA, resulting in rapid 
decline of classical scrapie outbreaks [3]. Unfortunately, 
A136R154R171 genotype does not provide resistance 
towards atypical scrapie [4].
We have previously demonstrated the high resistance 
of the goat K222-PrPC variant to a wide variety of classi-
cal scrapie isolates using transgenic (Tg) mice [5]. These 
results were confirmed by oral and intracerebral inocula-
tions of a natural classical scrapie isolate in goats express-
ing this polymorphism [6] and we therefore proposed 
the K222-PrPC variant as a good candidate for developing 
selective breeding programs in goat herds. These studies 
are very valuable to control the spread of prion diseases 
in animals, but also provide crucial information about 
the role of the host genotype in the prion pathobiology. 
In the present study, we analyze the role of K222-PrPC var-
iant on the resistance/susceptibility of goats to atypical 
scrapie using goat-PrP Tg mice.
Materials and methods
Ethics statements
Animal experiments were carried out in strict accord-
ance with the recommendations of the Code for Methods 
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and Welfare Considerations in Behavioral Research with 
Animals (Directive 86/609EC) and approved by the Com-
mittee on the Ethics of Animal Experiments (CEEA) of 
the Spanish Instituto Nacional de Investigación y Tec-
nología Agraria y Alimentaria (INIA); Permit Number: 
CEEA2011/050.
Transmission studies
Groups of 5–6 Tg mice (6–7 weeks old) expressing either 
the goat wild type (wt) PrPC (Q222-Tg501) or the K222-
PrPC variant (K222-Tg516) at two fold the PrPC levels in 
the goat brain [5] were intracerebrally inoculated into the 
right parietal lobe with 20  μL of 10% brain homogenate 
(w/v) from sheep and goats naturally infected with atypi-
cal scrapie (see Table 1 for isolate information). Mice were 
monitored daily and their neurological status assessed 
twice a week. Mice were humanely euthanized when the 
progression of the disease was evident or at the end of 
their life span [≈650 days post-inoculation (dpi)]. During 
necropsy, brains were sliced sagittally and one hemibrain 
was fixed in 10% buffered formalin for histopathological 
analysis. The remaining hemibrain was homogenized as 
10% (w/v) for the detection of proteinase K-resistant PrP 
(PrPres) by Western blot. Survival time was calculated as 
the mean number of survival dpi for all the mice positive 
for PrPres in the brain, with the standard error included, 
while attack rate was expressed as the proportion of 
PrPres-positive mice among the mice inoculated.
Western blotting
Brain tissue was homogenized in 5% glucose in distilled 
water in grinding tubes (Bio-Rad) and adjusted to 10% 
(w/v) by using a TeSeETM Precess 48TM homogenizer 
(Bio-Rad) following the manufacturer’s instructions. To 
determine the presence of PrPres in transgenic mouse 
brains, 100  µL of 10% brain homogenate were analyzed 
by Western blotting as previously described [7] with 
some modifications. Briefly, digestion was done with 
40 µg/mL of proteinase K in buffer 5% sarkosyl, 5% Tri-
ton X100, 1  M Urea and 16  mM Tris–HCl (pH 9.6) at 
60  °C for 15 min. Samples were electrophoresed in 12% 
Criterion XT Bis–Tris Gel (BioRad). For immunoblot-
ting, membranes were incubated with 12B2 PrP mono-
clonal antibody (epitope 93WGQGG97 of the sheep PrP 
sequence) at a final concentration of 1  μg/mL. Immu-
nocomplexes were detected with horseradish peroxi-
dase-conjugated anti-mouse IgG (Amersham Pharmacia 
Biotech) after incubating the membranes for 1  h, and 
blots were developed with chemiluminescent substrate 
ECL Select (GE Healthcare Amersham Biosciences). 
Images were captured using ChemiDoc XRS  +  System 
and then processed using Image Lab 5.2.1 Software.
Histopathological analysis
Formalin-fixed brains were trimmed, dehydrated, embed-
ded in paraffin-wax, cut to 4 µm thickness, de-waxed and 
rehydrated by standard procedures. For IHC demonstra-
tion of PrPSc accumulation, tissue sections were subjected 
to antigen retrieval and quenching of hydrogen peroxide, 
as described previously [8] and incubated with polyclonal 
PrP antibody R486 (APHA, Weybridge, UK; 240SPPVIL-
LISFLIFLI254 epitope of the sheep PrP sequence); the 
subsequent steps of the IHC procedure were performed 
by a commercial immunoperoxidase technique (Vector-
Elite ABC kit, Vector Laboratories) as per manufacturer’s 
instructions and sections were finally counterstained 
with Mayer’s haematoxylin. The PrPSc types considered 
included the intraneuronal (ITNR), intraglial (ITGL, 
intra-microglial and intra-astrocytic combined), stellate 
(STEL), fine particulate (PART), coalescing (COAL), lin-
ear (LINR) and plaques (PLAQ, vascular and non-vascu-
lar combined) as described elsewhere [8]. Plaques were 
only considered as such when they showed a homogene-
ous core and a radiate periphery (mature plaques), while 
in the absence of these features the dense accumulations 
of PrPSc were termed “coalescing”, without prejudice to 
them actually corresponding to primitive plaques.
Results
Tg mouse lines expressing the goat wild type PrPC 
(Q222-Tg501) and the K222-PrPC variant (K222-Tg516) were 
intracerebrally challenged with 3 natural cases of atypical 
Table 1 Description of natural atypical scrapie isolates
a Wild type (wt) sheep prion protein genotype: A136R154Q171/A136R154Q171.
b Wild type (wt) goat prion protein genotype: I142R154R211Q222S240/I142R154R211Q222S240.
c Instituto Vasco de Investigación y Desarrollo Agrario (NEIKER), Vizcaya, Spain.
d Istituto Zooprofilattico Sperimentale de Piemont, Torino (IZSTO) Italy (We than Dr. Pier Luigi Acutis for providing the Goat‑Sc I15 isolate).
e Laboratório de Patologia; Instituto Nacional de Investigação Agrária e Veterinária (INIAV); Lisboa, Portugal.
Isolate PrP genotype Description and references Supplier
Sheep‑Sc M45 wta Cerebellum from a natural atypical scrapie case in sheep NEIKERc
Goat‑Sc I15 wtb Brain from a natural atypical scrapie case in goat IZSTOd
Goat‑Sc 12‑09106 wt; H/H154 Cerebellum from a natural atypical scrapie case in goat INIAV
e
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scrapie (Table  1) and their susceptibilities assessed and 
compared following previously described methods [5].
Both Q222-Tg501 and K222-Tg516 mice succumbed to 
the inoculation of all atypical scrapie isolates with 100% 
attack rates (Table  2). For each isolate, Q222-Tg501 and 
K222-Tg516 mice displayed similar survival times which 
were longer than 300 dpi in all cases (Table 2).
PrPres was detected in the brains of all the inoculated 
Q222-Tg501 and K222-Tg516 mice by Western blot. PrPres 
glycoprofiles were characterized by a ladder-like pattern 
and a low unglycosylated band of around 7  kDa similar 
to that observed in their respective original sheep or goat 
isolates (Figure 1).
All infected Q222-Tg501 and K222-Tg516 mice showed 
PrPSc in their brains with indistinguishable immunohis-
tochemical phenotypes. PrPSc appeared as occasional, 
scattered coalescing or amorphous plaque-like deposits 
restricted to the molecular layer of the cerebellum while 
vacuolation was minimal in this area (Figure 2A, B). No 
PrPSc deposition or spongiform change were observed in 
any of the other brain areas examined, as exemplified by 
the hippocampus and thalamus in Figure 2C and D.
Discussion
Intracerebral inoculations of prions in transgenic mice 
expressing different PRNP polymorphic variants are highly 
valuable to point to a specific amino acid substitution as 
the unique mutation responsible for the resistance/suscep-
tibility of a species to a prion disease. Our results indicate 
that K222-PrPC variant replicates the atypical scrapie agent 
as efficiently as the wt-PrPC and thus, it might not be able 
to protect goats against the infection with this prion dis-
ease. However, this assumption must be confirmed by oral 
inoculation of Q/K222 goats since there is not always a cor-
relation between intracerebral inoculations in transgenic 
mouse models and field infections in natural hosts [9].
Intracerebral transmission of atypical scrapie in both 
Q222-Tg501 and K222-Tg516 mouse lines resulted in a 
prion disease characterized by noticeable long survival 
times (>300 dpi) and poor pathology in brain. These long 
survival times are consistent with the old age at which 
sheep and goats normally develop atypical scrapie either 
naturally (over 5  years of age) [4] or after intracerebral 
transmission (around 2.5 years of age) [10] and suggests 
that atypical scrapie is a slow infectious agent in its natu-
ral PrPC species context. In line with this view, mice over-
expressing 8- to 10-fold the sheep PrPC in their brains 
succumbed to the intracerebral inoculation of multi-
ple French atypical scrapie isolates only after more than 
400 dpi [11]. However, prolonged survival times are not 
exclusive of atypical scrapie agents since particular clas-
sical scrapie isolates can produce survival times longer 
than 500 dpi even after serial intracerebral passages in 
homozygous Q222-Tg501 mice (unpublished data).
The histological and immunohistochemical examina-
tions of the brains from all the atypical scrapie infected 
Q222-Tg501 and K222-Tg516 mice consistently revealed a 
mild accumulation of PrPSc restricted to the cerebellum 
with little or no vacuolation also limited to this brain 
area. These outcomes clearly contrast with the wide-
spread PrPSc and intense vacuolation observed in classi-
cal scrapie infected Q222-Tg501 mice or in BSE infected 
K222-Tg516 mice [5]; instead they correlate well with the 
particularly prominent PrPSc deposition in the cerebel-
lum of sheep and goats with natural atypical scrapie [12]. 
The PrPres glycoprofiles of all the atypical scrapie isolates 
were also maintained in both Q222-Tg501 and K222-Tg516 
mouse lines which, together with the survival times 
and the histological outcomes, further demonstrates 
Table 2 Transmission of atypical scrapie to Q222-Tg501 and 
K222-Tg516 mice
n/n0 attack rate expressed as the proportion of positive mice among the total 
inoculated mice
Isolate Mean survival time in days ± SD (n/n0)
Q222-Tg501 K222-Tg516
Sh‑Sc M45 443 ± 70 (9/9) 441 ± 131 (10/10)
Goat‑Sc I15 552 ± 78 (6/6) 552 ± 64 (6/6)
Goat‑Sc 12‑09106 331 ± 15 (7/7) 309 ± 34 (6/6)
Figure 1 Brain PrPres from Q222-Tg501 and K222-Tg516 mice 
inoculated with an atypical scrapie isolate. Immunoblots of brain 
PrPres detected with 12B2 mAb of atypical scrapie isolates before and 
after transmission in either Q222‑Tg501 or K222‑Tg516 mice. Sheep clas‑
sical scrapie and uninfected sheep brain were included on the right. 
Similar amounts of 10% brain homogenate were loaded in each lane 
for comparison. Both Q222‑Tg501 and K222‑Tg516 mice showed a simi‑
lar PrPres ladder pattern characteristic of atypical scrapie. Molecular 
masses (kDa) are shown on the right.
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the validity of our animal models to characterize prion 
strains of sheep and goats.
Susceptibility to prions and disease phenotypes are 
likely modulated by conformational properties of prion 
strains and the PrPC and PrPSc amino acid sequence 
[13]. Some host PrPC amino acid sequences may have 
greater “plasticity” or ability to misfold—as proposed 
for the unique susceptibility of bank voles to a wide vari-
ety of prion diseases [14] and to “in vitro” conversion 
experiments [15]—while others may show the opposite 
situation, locking PrPC and preventing its conversion by 
different prion strains. Nonetheless, the plasticity of the 
host PrPC would not explain why certain amino acid sub-
stitutions inhibit the replication of some prion strains but 
not others. A clear example is the goat K222 variant which 
provides high resistance against classical scrapie and 
bovine spongiform encephalopathy (BSE) from cattle—
being protective even in heterozygous mice and goats [5, 
6, 9]—but it is as efficient as the goat wt PrPC in repli-
cating sheep and goat-BSE [5] and atypical scrapie when 
intracerebrally inoculated. The resistance of the K222 
variant to classical scrapie was associated to the addi-
tional positive charge at codon 222 provided by the lysine 
amino acid, which could interfere with the PrPC:PrPSc 
interaction, abolishing or lowering the conversion rates 
of PrPC [16]. Similarly, the perturbations in the PrPC sur-
face charge distribution and structural rearrangements 
mainly localized at the β2–α2 loop region (residues 169–
179 in goat PrPC numbering) are likely to underlie the 
resistance of the human E/K219 variant against CJD [17].
More recently, the existence of critical initial PrPC–
PrPSc interaction sites during the templating of PrPC by 
different prions was proposed [18]. The involvement 
of specific PrPC areas in the strain-dependent replica-
tion of prions could account for the variable role of the 
K222-PrPC variant in the susceptibility to scrapie. While 
for classical scrapie polymorphic variants along the 
PrPC have been associated to modulate the suscepti-
bility to the disease, for atypical scrapie only few have 
been reported—A/V136, F/L141, R/H154 and Q/R171 [4, 
19]— that, interestingly, are all located within β1–α1 and 
β2–α2 loops. This area could be the critical segment for 
Figure 2 PrPSc accumulation in the brain of Q222-Tg501 and K222-Tg516 mice infected with Sheep-Sc M45. Immunohistochemistry with 
R486 PrP antibody and haematoxylin counterstaining. PrPSc remained located to the molecular layer of the cerebellum as amorphous coalescing 
or plaque‑like deposits (arrows) (A, B). Note the absence of PrPSc and vacuolation in the hippocampus and dorsal thalamus (C, D). Scale bars are 
100 µm (A, B) and 500 µm (C, D).
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atypical scrapie interaction with the host PrPC and there-
fore any amino acid exchange outside this segment would 
not affect the capacity of replication of the atypical scra-
pie, as observed in our transmission study in goat wt and 
K222-PrPC mice. In fact this area seems to be accessible 
in the abnormally folded aggregate of the atypical scrapie 
agent as suggested by the observation that the C-terminal 
part of atypical scrapie PrPSc can be specifically trimmed 
by PK [20]. In conclusion, although more information is 
still needed to decipher the mechanisms of prion con-
version, our study points to the involvement of specific 
PrPC areas in the strain-dependent replication of prions. 
Thus, strategies to fight prion diseases based on genotype 
breeding programs should be prion strain targeted.
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